| Fort Calhoun Clinic | |
|
4929 County Road P43 Fort Calhoun NE 68023-5066 | |
| (402) 468-4655 | |
| (402) 468-4633 |
| Full Name | Fort Calhoun Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 4929 County Road P43, Fort Calhoun, Nebraska |
| Authorized Official Name and Position | Amy Zimmer (CNE/VP PATIENT CARE SERVICES) |
| Authorized Official Contact | 4024262182 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Fort Calhoun Clinic 4929 County Road P43 Fort Calhoun NE 68023-5066 Ph: (402) 468-4655 | Fort Calhoun Clinic 4929 County Road P43 Fort Calhoun NE 68023-5066 Ph: (402) 468-4655 |
| NPI Number | 1417015207 |
|---|---|
| Provider Enumeration Date | 12/05/2006 |
| Last Update Date | 10/04/2023 |
| Medicare PECOS PAC ID | 0749190775 |
|---|---|
| Medicare Enrollment ID | O20100315000233 |
News Archive
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.
Blood pressure screening for children should start at age 3, according to the latest government diagnosis and treatment guidelines that were presented at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417015207 | NPI | - | NPPES |
| 07683 | Other | NE | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 79001 (Nebraska) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.
Blood pressure screening for children should start at age 3, according to the latest government diagnosis and treatment guidelines that were presented at the American Society of Hypertension's Nineteenth Annual Scientific Meeting.
› Verified 5 days ago
Td Nurse Practitioner Services, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4972 County Road 38, Fort Calhoun, NE 68023 Phone: 402-641-8822 |